BioAlberta’s Post

Great to see that The American Journal of Respiratory and Critical Care Medicine has recognised the fantastic work that is happening at Qureight 📰 Qureight's technology in lung fibrosis "represents a major step forward in the development of deep learning-based qCT" 💡and we are so proud to be part of their story! Check out the full editorial below! 👇 #venturecapital #vc #healthtech #startupnews #startups

https://lnkd.in/g5bWHfRV what an exciting breakthrough that shows why we struggle to bring innovation to the world's.... and what a great article making this so vivid and meaningful

Knowledge Creation: Turning What We Have Into What We Need Knowledge creation is, at its core, the process of transforming existing resources into something new. It’s fascinating to think that the same natural ingredients that were available to cavemen are still around us today, yet over millennia, humans have continuously innovated. Through this ingenuity, we’ve developed products and services that provide the comfort many of us enjoy today. Take, for instance, the use of human placenta in healing burn wounds—a striking example of leveraging what we have to address a medical need. Who would have thought such a solution existed within something so familiar? At its essence, knowledge creation is about using the resources at hand to generate what society needs. It’s a reminder that innovation doesn’t always require something new—often, it’s about seeing the potential in what we already possess. https://lnkd.in/gWJ2CvJk

We as humans are now living longer than ever. Advances to modern medicine, nutrition, and many other socio-social factors have increased the average human life expectancy. Unfortunately living for longer doesn’t always mean being healthy for longer & at the moment there is a large gap between health and life expectancy. This is where we exist. We aim to deliver world leading regenerative solutions to help Australian’s live healthier for longer. Regenerative Medicine Aims to restore cells and organs back to the original healthy state. We help surgeons, doctors & specialists deliver regenerative treatments to replace cells, tissue or organs that have been damaged by disease, trauma or congenital issues. At Allmedica we aim to be at the forefront of regenerative medicine in Australia & New Zealand. For more information visit allmedica.au

#MedicalForgeFriday 🚀 Deep Breath 🫁 solves a pressing problem of mortality in the intensive care units by collecting and processing ventilator data to enable physicians take timely and data-driven decisions about the patients' treatment. 40-50% of intensive care patients require continuous application of mechanical #ventilation (MV) as a life-saving intervention which is associated with patient-ventilator asynchrony (the mismatch between the patient's effort and ventilator support). Clinicians, even experts, fail at recognizing PVA at the bedside firstly because they spend less than 15% of their time with a patient, secondly because visual #PVA observation is not reliable due to the complexity of this phenomenon. Meet Deep Breath at 🥨Bits & Brezels Health Tech in Munich on June 5th and 6th, 2024! 🤝 #accelerator #startup #batch3

🚀 XS Innovations secures €1.1 million to revolutionise dialysis! 💡 Fantastic news for the biomedical community! XS Innovations, a pioneering spinout from Leiden University Medical Center and Delft University of Technology, has just closed a €1.1 million seed funding round. This funding will fast-track the development of their Dynamic AVF, a groundbreaking vascular access device designed to tackle the frequent complications associated with hemodialysis. 🌟 Dynamic AVF promises to significantly reduce complication rates and extend the lifespan of vascular access. By addressing critical issues like vascular access occlusion and heart failure, this innovation could immensely improve the quality of life for end-stage kidney disease (ESKD) patients. By 2024, around 4 million patients globally rely on hemodialysis, and 70% of them face severe complications with current technologies. The financial backing for XS Innovations came from an impressive consortium including FIRST Fund, Medtech TTT Fund, UNIIQ, Delft Enterprises, Libertatis Ergo Holding, and the Graduate Entrepreneur Fund. According to CEO Toon Stilma, this funding is pivotal for speeding up the commercialisation of the Dynamic AVF, making a tangible difference in patients' lives. I'd love to hear your thoughts on such innovative strides in medical technology! Engage with my post or send an email to luke.mcclean@lifescirecruitment.com for more insights. #MedTech #LifeSciences #Innovation

🎉 #GoodNews to jump-start your Monday! 🚀 Afynia Laboratories, guided by the visionary minds of founders Jocelyn Wessels, Ph.D., and Warren (Lauren) Foster, Ph.D., FCAHS proudly announces a milestone $2M pre-seed round, led by the Capital Angel Network.🌱 🔬With their revolutionary EndomiR test, they’re slashing the excruciating 7-year average diagnosis time for endometriosis, which affects countless women with chronic pelvic pain through unnecessary and invasive tests🩺💔 This significant advance in #WomensHealth is unfolding right in our backyard in #Hamilton and ties closely to Ontario universities like McMaster University. 🌟 Special shoutout to Suzanne Grant, CD, and all CAN members for their pivotal role in this venture. The work of Ontario's #AngelGroups is crucial in nurturing groundbreaking technologies that promise to improve and save lives🌐 📖 Dive deeper into how these former McMaster researchers are setting new standards in healthcare innovation, and why this initiative deserves your attention! 🔗 Read the full story from BetaKit here: https://lnkd.in/eFVUVm3E #afynialabs #HealthTech #Innovators #OntarioAngels #AfyniaLaboratories #HealthcareInnovation #EndometriosisAwareness #StartUpFunding #AngelInvestorsOntario #OntarioInnovates

Discover how researchers at North Carolina State University are pushing the boundaries of chronic wound treatment with their groundbreaking electric bandage. This technology could change the way we manage wound care forever! 🔬💡 Dive into the details and explore the potential of this promising development. Your next read awaits: https://bit.ly/4cj3Zjj #HealthTech #Innovation #WoundCare #NCSU #ScienceNews

Closed Loop Medicine and Pharmanovia have announced the launch of the OptiZest study, marking a significant milestone in the co-development of drug-plus-software combination therapies for hypertension. This innovative trial is the result of their 2023 partnership, aimed at revolutionizing precision medicine. https://lnkd.in/dnqCmwBZ The OptiZest study will evaluate the effectiveness of a personalized dose of Zestril (lisinopril) when paired with Closed Loop's cutting-edge Software-as-a-Medical Device (#SaMD) technology for dosing optimization. This combination aims to improve blood pressure control for patients at home, offering a tailored approach to hypertension management.

🔬 Research-Driven Results: Collaborating with leading experts, the SenLore™ Smart Boot’s aim is to enhance healing rates in lower extremity wounds. Our goal is to integrate pioneering technology to existing methods, spearheaded by visionary entrepreneurs, to revolutionize the healing process for DFUs. 👣 Enhanced Healing Process: The SenLore™ Smart Boot research and development is focused on how to treat challenging lower extremity wounds. It’s not just about faster healing; it’s about reducing complications and significantly improving patients’ quality of life. 🌟 Join us in our journey to heal and transform lives. Together, we can make a difference for the millions affected by DFUs. ... #Innovation #DiabeticFootUlcer #HealthTech #PatientCare ... The CSO of Adlore, Inc. Daryl Lawson is one of the contributors to this research paper.